COVID-19 Suspected myopericarditis without pulmonary involvement.

Heart Lung

Department of Internal Medicine, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, United States of America; Department of Internal Medicine, Division of Pulmonary and Critical Care, Nassau University Medical Center, East Meadow, New York, United States of America.

Published: March 2022

Myopericarditis is a rare consequence of COVID-19 infection. Although extremely rare, COVID-19 can present without pulmonary involvement, and there have been reports of isolated cardiac involvement in one prior case We report a case of a young African American man presenting with myopericarditis following a recently recovered COVID-19 infection. Complicated by ICU admission requiring vasopressors; with eventual resolution following initiation of aspirin and colchicine for myopericarditis. Life threatening myopericarditis can occur following resolution of COVID-19 disease. The degree of cardiac involvement correlates poorly to the severity of pulmonary involvement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501216PMC
http://dx.doi.org/10.1016/j.hrtlng.2021.10.001DOI Listing

Publication Analysis

Top Keywords

pulmonary involvement
12
covid-19 infection
8
cardiac involvement
8
covid-19
5
myopericarditis
5
involvement
5
covid-19 suspected
4
suspected myopericarditis
4
myopericarditis pulmonary
4
involvement myopericarditis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!